Academic institutions and pharma join to improve how imaging is used to monitor change and track drug response in desmoid tumors, moving toward new clinical trial endpoints.
by
by
Academic institutions and pharma join to improve how imaging is used to monitor change and track drug response in desmoid tumors, moving toward new clinical trial endpoints.
Every donation, no matter the size, helps us continue our mission.
© Desmoid Tumor Research Foundation (DTRF) | c/o CliftonLarsonAllen LLP, 50 Tice Blvd, Suite 175, Woodcliff Lake, NJ 07677